CLASS II ONGOING Drug recall · Reported 12 Apr 2023 · FDA Enforcement Report

Simvastatin Tablets, USP, 80 mg recalled by Preferred Pharmaceuticals

Preferred Pharmaceuticals is recalling Simvastatin Tablets, USP, 80 mg, distributed nationwide in the US. The recall was initiated on 23 Mar 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: B0222S, Exp 2/29/2024; Lot: F1121B, G2721L, Exp 11/30/2023.
Quantity recalled57 Bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0523-2023
FDA event ID
91952
Recalling firm
Preferred Pharmaceuticals, Anaheim, CA
Classification
Class II
Status
Ongoing
Recall initiated
23 Mar 2023
FDA classified
6 Apr 2023
Reported
12 Apr 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

23 Mar 2023Recall initiated by company
6 Apr 2023Classified by FDA+14 days
12 Apr 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Product as listed by the FDA

Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Is Simvastatin Tablets, USP, 80 mg recalled?

Yes. Preferred Pharmaceuticals recalled Simvastatin Tablets, USP, 80 mg on 23 Mar 2023. The recall is Class II and its status is Ongoing. Recall number D-0523-2023.

Why was it recalled?

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Which lots are affected?

Lot: B0222S, Exp 2/29/2024; Lot: F1121B, G2721L, Exp 11/30/2023.

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Preferred Pharmaceuticals

All 55

Other Simvastatin recalls

All 21